News
ILMN
--
0.00%
--
Illumina Inc. stock outperforms competitors on strong trading day
Shares of Illumina Inc. rallied 3.63% to $421.00 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...
marketwatch.com · 7h ago
PerkinElmer Inc. stock underperforms Monday when compared to competitors
Shares of PerkinElmer Inc. dropped 0.57% to $151.05 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...
marketwatch.com · 7h ago
Press Release: Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021
Dow Jones · 14h ago
Top Analyst Upgrades and Downgrades: American Eagle, Baidu, GameStop, Halliburton, Mosaic, Regeneron, Salesforce, Take-Two, Wells Fargo and More
247WallSt.com · 15h ago
Nucleic Acid Isolation and Purification Market expected to grow at a CAGR of ~5.0% |SWOT Analysis, Competitive Landscape, Business Opportunities and Forecast to 2029 | FMI Report
Jan 25, 2021 (MARKITWIRED via COMTEX) -- Future Market Insights (FMI), in its latest publication, outlines the future trajectory of the global nucleic acid...
Markitwired · 15h ago
The Asia Pacific single-cell analysis market is projected to reach USD 1,375 million by 2025 from USD 550 million in 2020, at a CAGR of 20.1%
New York, Jan 25, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asia...
GlobeNewswire · 15h ago
Baidu, Illumina, American Axle & Manufacturing, International Paper and KB Home highlighted as Zacks Bull and Bear of the Day
Zacks.com · 16h ago
Liquid Biopsy market Size, Share and Trend to exceed US $3,051.1 Mn by 2025 - Industry News
Jan 25, 2021 (Market Insight Reports) -- Global liquid biopsy market is anticipated to reach US $3,051.1 million by 2025, according to the latest research...
Market Insight Reports · 17h ago
DNA Polymerases Market |Global Opportunities, Size, Share, Emerging Trends, Technological Innovation and Forecasts
Japan, Japan, Mon, 25 Jan 2021 06:30:23 / Comserve Inc. / -- DNA Polymerases Market With Top Countries Data, Industry Analysis, Size, Share, Revenue,...
Comserve · 18h ago
Hemato Oncology Testing Market Analysis By Industry Growth, Size, Share, Demand, Trends and Research Report
Japan, Japan, Mon, 25 Jan 2021 05:15:39 / Comserve Inc. / -- Hemato Oncology Testing Market With Top Countries Data, Industry Analysis by Regions, Size,...
Comserve · 19h ago
global market for Genomic data analysis and interpretation is predicted to grow at a CAGR of 10.21% over the forecast period of 2020-2030
New York, Jan 25, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report...
GlobeNewswire · 19h ago
Transcriptomics Market | 2021 Healthcare Industry Analysis By COVID-19 Impact Forecast By Size, Growth, Share Estimation, Business, And Global Trends Analysis To 2026
Jan 25, 2021 (The Expresswire) -- Transcriptomics Market | 2021 COVID-19 Impact On Healthcare Industry Size, Growth Rate, Business, Share Estimation, Trends,...
The Express Wire · 19h ago
Transplant Diagnostics Market : Research By Production, Revenue, Growth Rate, Sales Value, Industry Trends, Impact Factors, SWOT Analysis
Japan, Japan, Mon, 25 Jan 2021 04:28:07 / Comserve Inc. / -- Transplant Diagnostics Market With Top Countries Data, Industry Analysis by Regions, Size,...
Comserve · 20h ago
Bear of the Day: Illumina (ILMN)
Bear of the Day: Illumina (ILMN)
Zacks · 20h ago
Breast Cancer Liquid Biopsy Market Size 2021 Research Report with Manufactures, Types, Applications, Opportunities, Strategies, Covid-19 Impact and Forecast to 2025
Jan 25, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." “Breast Cancer Liquid Biopsy Market”...
The Express Wire · 22h ago
Next Generation Cancer Diagnostic Devices Market 2021 Covid 19 Analysis with Top Countries Data: Industry Insights by Players, Regional Segmentation, Growth, Applications, Major Drivers, Value and Foreseen
Jan 24, 2021 (The Expresswire) -- Global“Next Generation Cancer Diagnostic DevicesMarket” Report 2021 - 2024 delivers the latest industry data and industry...
The Express Wire · 1d ago
Life Science Tools & Reagents Market Segmentation and Analysis by Recent Trends, consumption by Regional data, Development, Investigation, Growth by to 2026
Jan 24, 2021 (The Expresswire) -- Global "Life Science Tools and Reagents Market"(2021-2026) present scenario and growth prospects of pin-point analysis for...
The Express Wire · 1d ago
How Mike Speiser and Sutter Hill are changing the rules for venture investing
Investors are taking note of the success enjoyed by Sutter Hill Ventures, a longstanding firm that has gone big on incubating start-ups and growing them fast.
CNBC.com · 1d ago
Illumina Inc. stock underperforms Friday when compared to competitors despite daily gains
Shares of Illumina Inc. inched 0.34% higher to $406.25 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...
marketwatch.com · 3d ago
Insider Sales at Illumina (ILMN) are Significant and Extend the Selling Trend of Last Quarter
MT Newswires · 3d ago
Webull provides a variety of real-time ILMN stock news. You can receive the latest news about Illumina through multiple platforms. This information may help you make smarter investment decisions.
About ILMN
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.
More